Peptide KPV
This peptide has been shown in numerous studies to have anti-inflammatory properties and also to inhibit the formation of tumors in the body. It is applied topically to the skin, and has been shown to be particularly effective in the skin condition called Psoriasis, which is considered an autoimmune disease. Because of its anti-inflammatory activity, KPV seems to benefit patients who have many other autoimmune conditions, which have in common an inflammatory process which attacks different areas of the body depending upon which particular condition is manifesting itself. One study published in Endocrinolgy Review 2008, discusses it inFuture Perspectives for the Treatment of Immune-Mediated Inflammatory Disease.